R. Tony Tripeny, Director at MESA LABORATORIES INC /CO/ (MLAB), bought 900 shares at $113.69 ($102K) on 2026-08-13, disclosed to the SEC on 2026-08-17.
Mesa Laboratories Director R. Tony Tripeny purchased 900 shares for $113.69 on August 13, 2026, marking the largest insider purchase in the company's history. This significant buy signals insider confidence in the stock's valuation, especially given the recent earnings beat and margin expansion.
The stock is trading at $101.19, down 9.64% from its 52-week high of $111.98, but has gained 46.92% over the past year. The recent 30-day performance shows a modest 4.45% increase, suggesting the stock is consolidating after a strong run.
1) Q1 2027 earnings on August 11, 2026, showed adjusted operating income surged nearly 20% and revenue growth of 1%. 2) The company is addressing fulfillment issues in its Sterilization and Disinfection Control business, which could drive future growth. 3) The largest-ever insider purchase by a Director acts as a catalyst for investor confidence.
1) The stock is trading at a high P/E ratio of 126.16, which may limit upside if growth slows. 2) Short interest represents 8.39% of the float, indicating potential volatility if the stock reverses course.
Clearly above the average filing.
| Filing → |
| ORGN | BUY | 2023-09-06 | $200K | — | Filing → |
| MLAB | BUY | 2022-08-09 | $100K | — | Filing → |
| GLW | SELL | 2021-03-10 | $3.5M | — | Filing → |